Major shareholder announcement
21 Juin 2024 - 11:53AM
Major shareholder announcement
June 21, 2024
Company announcement No. 22
Pursuant to Section 30 of the Danish Capital
Markets Act, Novonesis hereby announces that Novo Nordisk Fonden
has on its own behalf and on behalf of its wholly owned subsidiary
Novo Holdings A/S notified Novonesis, that as of yesterday, Novo
Nordisk Fonden and Novo Holdings A/S, indirectly and directly,
respectively, holds a total of 53,743,600 A-shares (nominally DKK
107,487,200) and 65,672,555 B-shares (nominally DKK 131,345,110)
corresponding to 25.50% of the entire issued share capital and
63.35% of the total voting rights in Novozymes A/S, part of
Novonesis Group.
|
Contact information |
|
|
| Tobias Bjorklund+45
3077 8682tobb@novonesis.com |
|
| Anders Enevoldsen+45
5350 1453adev@novonesis.com |
|
| Disa Tuominen+45 6038
5826ditu@novonesis.com |
|
- 2024_22_Major_Shareholders_Announcement
Novonesis AS (TG:NZM2)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Novonesis AS (TG:NZM2)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
